Biotech Values

[flatlander_60048]

I have no position in EMIS.

The statement in the last Qtrly rept that they only had sufficient cash to remain solvent into February 2010 was enough to dissuade me. I agree that the Alpha piece was worthless. Still NVS' involvement adds some credibility. I'm also certain Icahn would rather not flush his money down a bottomless pit without decent potential upside.

Either way, I'll play it through NVS rather than EMIS.

Thanks

FL